Acute myeloid leukemia with t(10;11): A pathological entity with distinct clinical presentation

Courtney D. DiNardo, Guilin Tang, Naveen Pemmaraju, Sa A. Wang, Allison Pike, Guillermo Garcia-Manero, Jorge Cortes, Carlos Bueso-Ramos, Hagop M. Kantarjian

Research output: Contribution to journalArticle

Abstract

t(10;11)(p12;q23) is a rare recurrent translocation involving the mixed lineage leukemia (MLL) gene translocation, most commonly seen in pediatric and young adult acute myeloid leukemia (AML), associated with early morbidity including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure from leukocytosis. With supportive care, first remissions are frequently attained, but patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes. Introduction: Acute myeloid leukemias with MLL rearrangements are frequently associated with myelomonocytic and monoblastic/monocytic morphology, with an increased risk of leukocytosis and leukostasis-related complications. Yet, little is known regarding the clinical presentation of adult AML patients with MLL translocations based on the specific translocation partner. Patients and Methods: Two recent AML cases with t(10;11)(p12;q23) translocations are detailed, with their shared presenting symptoms highlighted, followed by a review of the current literature. Results: The specific t(10;11)(p12;q23) MLL translocation is a rare recurrent translocation partner, most commonly seen in pediatric and young adult AML. A high incidence of early morbidity from leukocytosis-related complications are frequently seen, including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure, even without a true leukocytosis. Conclusion: With prompt therapy and intensive supportive care first remissions are frequently attained, however, patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes.

Original languageEnglish (US)
Pages (from-to)47-51
Number of pages5
JournalClinical Lymphoma, Myeloma and Leukemia
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Acute Myeloid Leukemia
Leukocytosis
Leukemia
Tumor Lysis Syndrome
Young Adult
Leukostasis
Pediatrics
Morbidity
Recurrence
Critical Care
Incidence
Genes
Therapeutics

Keywords

  • AML
  • DIC
  • Leukostasis
  • MLL
  • TLS

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

DiNardo, C. D., Tang, G., Pemmaraju, N., Wang, S. A., Pike, A., Garcia-Manero, G., ... Kantarjian, H. M. (2015). Acute myeloid leukemia with t(10;11): A pathological entity with distinct clinical presentation. Clinical Lymphoma, Myeloma and Leukemia, 15(1), 47-51. https://doi.org/10.1016/j.clml.2014.06.022

Acute myeloid leukemia with t(10;11) : A pathological entity with distinct clinical presentation. / DiNardo, Courtney D.; Tang, Guilin; Pemmaraju, Naveen; Wang, Sa A.; Pike, Allison; Garcia-Manero, Guillermo; Cortes, Jorge; Bueso-Ramos, Carlos; Kantarjian, Hagop M.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 15, No. 1, 01.01.2015, p. 47-51.

Research output: Contribution to journalArticle

DiNardo, CD, Tang, G, Pemmaraju, N, Wang, SA, Pike, A, Garcia-Manero, G, Cortes, J, Bueso-Ramos, C & Kantarjian, HM 2015, 'Acute myeloid leukemia with t(10;11): A pathological entity with distinct clinical presentation', Clinical Lymphoma, Myeloma and Leukemia, vol. 15, no. 1, pp. 47-51. https://doi.org/10.1016/j.clml.2014.06.022
DiNardo, Courtney D. ; Tang, Guilin ; Pemmaraju, Naveen ; Wang, Sa A. ; Pike, Allison ; Garcia-Manero, Guillermo ; Cortes, Jorge ; Bueso-Ramos, Carlos ; Kantarjian, Hagop M. / Acute myeloid leukemia with t(10;11) : A pathological entity with distinct clinical presentation. In: Clinical Lymphoma, Myeloma and Leukemia. 2015 ; Vol. 15, No. 1. pp. 47-51.
@article{41972b9d63ba4368805d00a52a8ba028,
title = "Acute myeloid leukemia with t(10;11): A pathological entity with distinct clinical presentation",
abstract = "t(10;11)(p12;q23) is a rare recurrent translocation involving the mixed lineage leukemia (MLL) gene translocation, most commonly seen in pediatric and young adult acute myeloid leukemia (AML), associated with early morbidity including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure from leukocytosis. With supportive care, first remissions are frequently attained, but patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes. Introduction: Acute myeloid leukemias with MLL rearrangements are frequently associated with myelomonocytic and monoblastic/monocytic morphology, with an increased risk of leukocytosis and leukostasis-related complications. Yet, little is known regarding the clinical presentation of adult AML patients with MLL translocations based on the specific translocation partner. Patients and Methods: Two recent AML cases with t(10;11)(p12;q23) translocations are detailed, with their shared presenting symptoms highlighted, followed by a review of the current literature. Results: The specific t(10;11)(p12;q23) MLL translocation is a rare recurrent translocation partner, most commonly seen in pediatric and young adult AML. A high incidence of early morbidity from leukocytosis-related complications are frequently seen, including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure, even without a true leukocytosis. Conclusion: With prompt therapy and intensive supportive care first remissions are frequently attained, however, patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes.",
keywords = "AML, DIC, Leukostasis, MLL, TLS",
author = "DiNardo, {Courtney D.} and Guilin Tang and Naveen Pemmaraju and Wang, {Sa A.} and Allison Pike and Guillermo Garcia-Manero and Jorge Cortes and Carlos Bueso-Ramos and Kantarjian, {Hagop M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.clml.2014.06.022",
language = "English (US)",
volume = "15",
pages = "47--51",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "1",

}

TY - JOUR

T1 - Acute myeloid leukemia with t(10;11)

T2 - A pathological entity with distinct clinical presentation

AU - DiNardo, Courtney D.

AU - Tang, Guilin

AU - Pemmaraju, Naveen

AU - Wang, Sa A.

AU - Pike, Allison

AU - Garcia-Manero, Guillermo

AU - Cortes, Jorge

AU - Bueso-Ramos, Carlos

AU - Kantarjian, Hagop M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - t(10;11)(p12;q23) is a rare recurrent translocation involving the mixed lineage leukemia (MLL) gene translocation, most commonly seen in pediatric and young adult acute myeloid leukemia (AML), associated with early morbidity including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure from leukocytosis. With supportive care, first remissions are frequently attained, but patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes. Introduction: Acute myeloid leukemias with MLL rearrangements are frequently associated with myelomonocytic and monoblastic/monocytic morphology, with an increased risk of leukocytosis and leukostasis-related complications. Yet, little is known regarding the clinical presentation of adult AML patients with MLL translocations based on the specific translocation partner. Patients and Methods: Two recent AML cases with t(10;11)(p12;q23) translocations are detailed, with their shared presenting symptoms highlighted, followed by a review of the current literature. Results: The specific t(10;11)(p12;q23) MLL translocation is a rare recurrent translocation partner, most commonly seen in pediatric and young adult AML. A high incidence of early morbidity from leukocytosis-related complications are frequently seen, including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure, even without a true leukocytosis. Conclusion: With prompt therapy and intensive supportive care first remissions are frequently attained, however, patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes.

AB - t(10;11)(p12;q23) is a rare recurrent translocation involving the mixed lineage leukemia (MLL) gene translocation, most commonly seen in pediatric and young adult acute myeloid leukemia (AML), associated with early morbidity including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure from leukocytosis. With supportive care, first remissions are frequently attained, but patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes. Introduction: Acute myeloid leukemias with MLL rearrangements are frequently associated with myelomonocytic and monoblastic/monocytic morphology, with an increased risk of leukocytosis and leukostasis-related complications. Yet, little is known regarding the clinical presentation of adult AML patients with MLL translocations based on the specific translocation partner. Patients and Methods: Two recent AML cases with t(10;11)(p12;q23) translocations are detailed, with their shared presenting symptoms highlighted, followed by a review of the current literature. Results: The specific t(10;11)(p12;q23) MLL translocation is a rare recurrent translocation partner, most commonly seen in pediatric and young adult AML. A high incidence of early morbidity from leukocytosis-related complications are frequently seen, including diffuse intravascular coagulation and tumor lysis syndrome with multiorgan system failure, even without a true leukocytosis. Conclusion: With prompt therapy and intensive supportive care first remissions are frequently attained, however, patients have a high risk of relapse, extramedullary disease, and poor long-term outcomes.

KW - AML

KW - DIC

KW - Leukostasis

KW - MLL

KW - TLS

UR - http://www.scopus.com/inward/record.url?scp=84926986352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926986352&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2014.06.022

DO - 10.1016/j.clml.2014.06.022

M3 - Article

C2 - 25081372

AN - SCOPUS:84926986352

VL - 15

SP - 47

EP - 51

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2650

IS - 1

ER -